U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Fluvoxamine ER Capsules
Status: Currently in Shortage
»Date first posted: 02/05/2019
»Therapeutic Categories: Psychiatry

Expand all

Par Pharmaceutical (Revised 05/24/2022)

Company Contact Information:
800-828-9393, option 5 then option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg. 30’s count (NDC 10370-175-11) A limited inventory will be available in June, July and August 2022. Estimated recovery September 2022 Delay in shipping of the drug
150 mg. 30’s count (NDC 10370-176-11) A limited inventory will be available in June, July and August 2022. Estimate recovery October 2022 Delay in shipping of the drug

Teva Pharmaceuticals (Reverified 07/01/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03) Available Requirements related to complying with good manufacturing practices
Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03) Available Requirements related to complying with good manufacturing practices
Back to Top